5N PlusFPLSF -12.58%73 Debt-to-EBITDA is 1.17 as of Mar. 2026, which is 61% below its 10-year median of 2.97. GuruFocus rates FPLSF with a GF Score™ of 73/100 and a GF Value™ of $7.65 (Significantly Overvalued). Among 1,231 Chemicals companies, 5N Plus ranks better than 62.06% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for 5N Plus's Debt-to-EBITDA or its related term are showing as below:
FPLSF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.43 Med: 2.97 Max: 30.84
Current: 1.43
During the past 13 years, the highest Debt-to-EBITDA Ratio of 5N Plus was 30.84. The lowest was 1.43. And the median was 2.97.
FPLSF's Debt-to-EBITDA is ranked better than 62.06% of 1231
companies
in the Chemicals industry
Industry Median: 2.17
vs FPLSF: 1.43
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
5N Plus Debt-to-EBITDA Related Terms
5N Plus Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for 5N Plus's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, 5N Plus's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
5N Plus Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, 5N Plus's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where 5N Plus's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
5N Plus (FPLSF) has a Debt-to-EBITDA of 1.17 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on 5N Plus. This is 61% below median its historical median of 2.97. Over the past decade, 5N Plus' Debt-to-EBITDA has ranged from 1.43 to 30.84. According to the industry distribution chart, 5N Plus ranks #467 out of 1231 companies in the Chemicals industry, placing it in the top 37.9%.
Is 5N Plus' Debt-to-EBITDA too high?
5N Plus' current Debt-to-EBITDA of 1.17 is 61% below median its 10-year median of 2.97. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 30.84. The Chemicals industry median Debt-to-EBITDA is 2.17. 5N Plus' value of 1.17 is 46.1% below this industry median. Based on the distribution chart, 5N Plus ranks #467 out of 1231 companies in the Chemicals industry, which is above the industry midpoint. Overall, 5N Plus has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 5N Plus' Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, 5N Plus ranks #467 out of 1231 companies for Debt-to-EBITDA. This puts 5N Plus in the upper half of its industry. The industry median Debt-to-EBITDA is 2.17. 5N Plus' value of 1.17 is 46.1% below this benchmark. Historically, 5N Plus' own Debt-to-EBITDA has ranged from 1.43 to 30.84 over the past decade. While the company's 10-year median is 2.97 vs. the industry median of 2.17, 5N Plus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.17, based on 1,231 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 5N Plus's current Debt-to-EBITDA of 1.17 is 46.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on 5N Plus. For the Chemicals industry, the median Debt-to-EBITDA is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 5N Plus's current Debt-to-EBITDA is 1.17, which is 61% below median its own 10-year median of 2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 5N Plus stock overvalued right now?
Based on GuruFocus' analysis, 5N Plus (FPLSF) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.65, compared to a current price of $28.00 — trading 266% above its estimated fair value. The current Debt-to-EBITDA is 1.17, which is 61% below median its 10-year median of 2.97 and 46.1% below the Chemicals industry median of 2.17. 5N Plus' overall GF Score™ is 73/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For 5N Plus (FPLSF), the current Debt-to-EBITDA is 1.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 5N Plus (FPLSF) Overvalued in 2026?
Based on GuruFocus' analysis, 5N Plus stock appears to be overvalued.
The current stock price of $28.00 is trading 266% above its estimated GF Value™ of $7.65.
GuruFocus considers 5N Plus to be Significantly Overvalued.
Key valuation signals for FPLSF:
Debt-to-EBITDA: 1.17 (61% below median its 10-year median of 2.97)
GF Value™: $7.65 vs. price of $28.00 (266% above fair value)
Industry Position: 46.1% below the Chemicals median (#467 of 1231)
No single metric tells the full story. See the FPLSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
5N Plus Inc is a Canadian-based company producing specialty semiconductors and performance materials. It operates in two segments: Specialty Semiconductors and Performance Materials. The Specialty Semiconductors segment manufactures and sells products used in several applications such as renewable energy, space satellites, and imaging. The Performance Materials segment manufactures and sells products that are used in several applications in pharmaceutical & healthcare, industrial, and catalytic and extractive. Main products are sold as active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial-grade metals, alloys, and engineered powders. The maximum revenue is derived from the Specialty Semiconductors segment.
73GF Score
Get the complete analysis for FPLSF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FPLSF has been successfully added to your 
